Clarkston Capital Partners’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Sell
1,849,288
-355,500
-16% -$3.26M 1.4% 25
2026
Q1
$20.5M Sell
2,204,788
-9,123,882
-81% -$89.8M 1.56% 24
2025
Q4
$79.2M Sell
11,328,670
-364,580
-3% -$2.29M 1.83% 20
2025
Q3
$66.8M Sell
11,693,250
-2,312,475
-17% -$12.3M 1.44% 24
2025
Q2
$66.9M Buy
14,005,725
+7,729,650
+123% +$44.4M 1.42% 25
2025
Q1
$54.4M Buy
6,276,075
+3,409,409
+119% +$35.7M 1.07% 25
2024
Q4
$34.8M Buy
+2,866,666
New +$40.1M 0.67% 32

Other funds holding NEOG

Clarkston Capital Partners's NEOG Position: Q2 2026 in Review

Clarkston Capital Partners reduced its Neogen (NEOG) stake by 16% in Q2 2026, selling an estimated $3.26M and leaving 1,849,288 shares worth $16.6M. The position accounts for 1.4% of the portfolio, ranked #25.

Clarkston Capital Partners first reported a position in NEOG in Q4 2024 and has held it in 7 quarters since. The position peaked at $79.2M in Q4 2025. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Clarkston Capital Partners held 1,849,288 shares of Neogen worth $16.6M as of Q2 2026.
  • Clarkston Capital Partners sold 355,500 Neogen shares in Q2 2026, an estimated $3.26M.
  • Neogen made up 1.4% of Clarkston Capital Partners's portfolio in Q2 2026, its #25 holding.
  • Clarkston Capital Partners first reported a position in Neogen in Q4 2024 and has held it in 7 quarters since.
  • Clarkston Capital Partners's Neogen position peaked at $79.2M in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Clarkston Capital Partners's 13F filing for Q2 2026, filed 11 Aug 2026.